Dr. Christina Smolke, Chief Executive Officer and Co-Founder of Antheia and professor of bioengineering and chemical engineering at Stanford University, is a pioneer in the fields of synthetic biology and metabolic engineering. At Stanford, her team led the breakthrough research to engineer baker’s yeast to produce some of the most complex and valuable plant-based medicines known to humankind, including opioids, noscapinoids, and tropane alkaloids. At Antheia, her vision and leadership has enabled a synthetic biology platform that dramatically expands the diversity and complexity of molecules that can be reconstructed, enabling new possibilities for drug discovery as well as rapid, localized, on-demand drug manufacturing at scale.
.svg)
